Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation ...Middle East

Anticancer drug utilizing Trans-splicing Ribozyme technology Second Fast Track Designation following brain cancer approval SEONGNAM, South Korea, Feb. 18, 2025 /PRNewswire/ -- Rznomics announced on the 14th that its anticancer drug, RZ-001, has received Fast Track Designation from the U.S....

Hence then, the article about rznomics inc liver cancer drug candidate secures fast track designation was published today ( Tuesday 18/02/2025 - 06:16 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation )

Also on site :

• Sinner beats Alcaraz in straight sets to win Monte Carlo; reclaim No.1 spot
• TCOM Investors Have Opportunity to Lead Trip.com Group Limited Securities Fraud Lawsuit with the Schall Law Firm
• Zohran Mamdani celebrates ‘pothole politics’ in a raucous rally marking 100 days as NYC mayor